The Center for Digital Democracy is calling for new regulations on how pharmaceutical companies market their products, reports Tech Daily Dose. In a Food and Drug Administration filing, the group says the companies' use of behavioral targeting poses risks to consumers, the report states. The FDA is seeking comments through this week on "how to apply existing regulations to promotion in...newer media." In the filing, the CDD writes that "Few U.S. health consumers are aware that they are being identified, labeled, profiled and tracked on the Internet while they search for access information on specific conditions or concerns."
If you want to comment on this post, you need to login.